Glycan susceptibility factors in autism spectrum disorders
Authors:
- 1 October 2016
- journal article
- review article
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 51, 104-114
Abstract
No abstract availableKeywords
Funding Information
- NIH (T32 HL086344-08)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR64202)
- National Heart, Lung, and Blood Institute (HL107150)
- Cure Sanfilippo Foundation and the Lubkin Fund
This publication has 91 references indexed in Scilit:
- Expanding the 3-O-Sulfate Proteome—Enhanced Binding of Neuropilin-1 to 3-O-Sulfated Heparan Sulfate Modulates Its ActivityACS Chemical Biology, 2016
- Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic DiseaseNeuron, 2015
- Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophyMolecular Autism, 2015
- Analysis of site-specificN-glycan remodeling in the endoplasmic reticulum and the GolgiGlycobiology, 2015
- Neurological Aspects of Human Glycosylation DisordersAnnual Review of Neuroscience, 2015
- Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum DisordersThe American Journal of Human Genetics, 2014
- The role of protein N-glycosylation in neural transmissionGlycobiology, 2014
- Characterization of a 520 kb deletion on chromosome 15q26.1 including ST8SIA2 in a patient with behavioral disturbance, autism spectrum disorder, and epilepsyAmerican Journal of Medical Genetics Part A, 2013
- Mutations in the Heparan-Sulfate Proteoglycan Glypican 6 (GPC6) Impair Endochondral Ossification and Cause Recessive OmodysplasiaThe American Journal of Human Genetics, 2009
- Specific modification of heparan sulphate is required for normal cerebral cortical developmentMechanisms of Development, 2003